Literature DB >> 15509767

Neural induction requires BMP inhibition only as a late step, and involves signals other than FGF and Wnt antagonists.

Claudia Linker1, Claudio D Stern.   

Abstract

A dominant molecular explanation for neural induction is the 'default model', which proposes that the ectoderm is pre-programmed towards a neural fate, but is normally inhibited by endogenous BMPs. Although there is strong evidence favouring this in Xenopus, data from other organisms suggest more complexity, including an involvement of FGF and modulation of Wnt. However, it is generally believed that these additional signals also act by inhibiting BMPs. We have investigated whether BMP inhibition is necessary and/or sufficient for neural induction. In the chick, misexpression of BMP4 in the prospective neural plate inhibits the expression of definitive neural markers (Sox2 and late Sox3), but does not affect the early expression of Sox3, suggesting that BMP inhibition is required only as a late step during neural induction. Inhibition of BMP signalling by the potent antagonist Smad6, either alone or together with a dominant-negative BMP receptor, Chordin and/or Noggin in competent epiblast is not sufficient to induce expression of Sox2 directly, even in combination with FGF2, FGF3, FGF4 or FGF8 and/or antagonists of Wnt signalling. These results strongly suggest that BMP inhibition is not sufficient for neural induction in the chick embryo. To test this in Xenopus, Smad6 mRNA was injected into the A4 blastomere (which reliably contributes to epidermis but not to neural plate or its border) at the 32-cell stage: expression of neural markers (Sox3 and NCAM) is not induced. We propose that neural induction involves additional signalling events that remain to be identified.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15509767     DOI: 10.1242/dev.01445

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  80 in total

1.  FGF/MAPK signaling is required in the gastrula epiblast for avian neural crest induction.

Authors:  Timothy J Stuhlmiller; Martín I García-Castro
Journal:  Development       Date:  2011-11-30       Impact factor: 6.868

Review 2.  Developmental origin of neural stem cells: the glial cell that could.

Authors:  Laura Grabel
Journal:  Stem Cell Rev Rep       Date:  2012-06       Impact factor: 5.739

3.  Cadherin 6B induces BMP signaling and de-epithelialization during the epithelial mesenchymal transition of the neural crest.

Authors:  Ki-Sook Park; Barry M Gumbiner
Journal:  Development       Date:  2010-07-07       Impact factor: 6.868

Review 4.  In Vitro Models for Neurogenesis.

Authors:  Hassan Azari; Brent A Reynolds
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-06-01       Impact factor: 10.005

Review 5.  Epigenetic regulation of early neural fate commitment.

Authors:  Yunbo Qiao; Xianfa Yang; Naihe Jing
Journal:  Cell Mol Life Sci       Date:  2016-01-22       Impact factor: 9.261

Review 6.  Current perspectives on the genetic causes of neural tube defects.

Authors:  Patrizia De Marco; Elisa Merello; Samantha Mascelli; Valeria Capra
Journal:  Neurogenetics       Date:  2006-08-29       Impact factor: 2.660

7.  Default neural induction: neuralization of dissociated Xenopus cells is mediated by Ras/MAPK activation.

Authors:  Hiroki Kuroda; Luis Fuentealba; Atsushi Ikeda; Bruno Reversade; E M De Robertis
Journal:  Genes Dev       Date:  2005-05-01       Impact factor: 11.361

Review 8.  FGF signalling: diverse roles during early vertebrate embryogenesis.

Authors:  Karel Dorey; Enrique Amaya
Journal:  Development       Date:  2010-11       Impact factor: 6.868

9.  A role for Syndecan-4 in neural induction involving ERK- and PKC-dependent pathways.

Authors:  Sei Kuriyama; Roberto Mayor
Journal:  Development       Date:  2009-01-14       Impact factor: 6.868

10.  MiR-135b is a direct PAX6 target and specifies human neuroectoderm by inhibiting TGF-β/BMP signaling.

Authors:  Akshay Bhinge; Jeremie Poschmann; Seema C Namboori; Xianfeng Tian; Sharon Jia Hui Loh; Anna Traczyk; Shyam Prabhakar; Lawrence W Stanton
Journal:  EMBO J       Date:  2014-05-06       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.